February 7, 2014
The landscape of hepatitis C (HCV) management has undergone a near-fundamental transformation over the past couple of years. As new treatment options puff up like popcorn kernels on a hot stove and our understanding of the virus deepens, it's important to revisit what's changed -- and what further changes 2014 may hold in store.
Late in 2013, Andrea Cox, M.D., Ph.D., an associate professor of medicine at Johns Hopkins University School of Medicine, presented an update on HCV coinfection for an audience of HIV care providers. Read on for a summary of key points from her talk, including selected slides (which have been reposted with her permission).
Myles Helfand is the editorial director of TheBody.com and TheBodyPRO.com.
Follow Myles on Twitter: @MylesatTheBody.
|AIDS 2014 Video Blog #1: At MSM Global Forum, the Shock of Tragedy and the Road Forward|
|Coverage of AIDS 2014: The 20th International AIDS Conference|
|World Without AIDS: Update on HIV Cure and Vaccine Research|
|2 Australian Men "Cleared" of HIV After Bone Marrow Transplants|
|An Airplane, a Missile, and an Unfathomable Moment in the War Against HIV|
|AIDS 2014 Video Blog #2: Criminals and Mannequins, Both Fighting HIV Stigma|